Development of asolectin-based liposomal formulation for controlled and targeted delivery of erlotinib as a model drug for EGFR monotherapy
Snehal Pardeshi(Central Drug Research Institute), Manish K. Chourasia(Central Drug Research Institute), Pankaj Kumar Singh(Lovely Professional University), Amrendra Tiwari(Central Drug Research Institute), Pavan Kumar Yadav(Central Drug Research Institute), Uday Titame(Central Drug Research Institute)
Cited by 5
Related Papers
Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos
|Journal of Controlled Release|2021|124
Gold nanoparticles: New routes across old boundaries
|Advances in Colloid and Interface Science|2019|114
Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response
|Journal of Controlled Release|2014|81
Correlation of Particulate Dispersion Stability with the Strength of Self-Assembled Surfactant Films
|Langmuir|2000|79
Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development
|Pharmaceutics|2022|79